Related Experiment Videos
Medical aid program for chronic pediatric diseases of specified categories in Japan: current status and future
Yan-Hong Gu1, Tadaaki Kato, Shohei Harada
1Department of Health Policy, National Research Institute for Child Health and Development, Tokyo, Japan. gyh@nch.go.jp
Background:
In 1974 the Medical Aid Program for Chronic Pediatric Diseases of Specified Categories (MAPChD) was established in Japan, and the national registration of MAPChD beneficiaries was initiated in 1998. In 2005, MAPChD became legal. The purpose of the present study was to analyze the newest registration data and discuss the future prospects of MAPChD. The differences in MAPChD content before and after legislation were compared.
Methods:
The subjects were MAPChD-registered patients whose guardians had signed a consent document for the children to join a MAPChD research program during the fiscal years 2002-2003. The nationwide electronic registration data were gathered and analyzed, and the official documents about MAPChD were reviewed and summarized.
Results:
Given that the overall population was aged 0-19 years, there were four MAPChD beneficiaries for every 1000 children in Japan. Moreover, the prolonged survival of MAPChD patients was accompanied by an increasing prevalence of complications. The percentages of MAPChD beneficiaries who did not sign a consent document for research were 3.1% and 6.3% in 2002 and 2003, respectively. Following the legislation, both inpatients and outpatients younger than 20 years with any of 514 chronic diseases became eligible, and MAPChD began providing welfare services to these patients.
Conclusions:
The establishment of a MAPChD database is necessary for further research. It is expected that, in future, more beneficiaries of MAPChD will join the research program. One of the major challenges faced by long-term survivors of childhood MAPChD diseases is making the transition from a specialized pediatric care facility to an adult health care system.
Insights
The Medical Aid Program for Chronic Pediatric Diseases of Specified Categories (MAPChD) in Japan expanded its eligibility and services after legislation in 2005. Further research requires a dedicated MAPChD database to support long-term survivors transitioning to adult care.
Area of Science:
- Pediatric Health Policy
- Chronic Disease Management
- Public Health Surveillance
Background:
- Established in 1974, the Medical Aid Program for Chronic Pediatric Diseases of Specified Categories (MAPChD) in Japan initiated national registration in 1998 and became legal in 2005.
- The program aims to provide support for children with specified chronic diseases.
Purpose of the Study:
- To analyze the latest MAPChD registration data.
- To discuss the future prospects of the MAPChD program.
- To compare the program's services before and after its legalization.
Main Methods:
- Analysis of nationwide electronic registration data from fiscal years 2002-2003 for MAPChD-registered patients with guardian consent.
- Review and summarization of official MAPChD documents.
Main Results:
- MAPChD beneficiaries represented 0.4% of the pediatric population (0-19 years) in Japan.
- Increased patient survival correlated with a rise in complications.
- Post-legislation, eligibility expanded to all inpatients and outpatients under 20 with 514 chronic diseases, with MAPChD providing welfare services.
Conclusions:
- A dedicated MAPChD database is crucial for advancing research.
- Increased participation of beneficiaries in research programs is anticipated.
- Facilitating the transition from pediatric to adult healthcare systems is a key challenge for long-term survivors.
Related Concept Videos
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:30Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:28Chronic Kidney Disease III: Interprofessional Care
01:20Chronic Obstructive Pulmonary Disease-I: Introduction